Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

347 ARTÍCULOS , VIENDO DEL 316 AL 330

Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier

Banks WA.

Adv Drug Deliv Rev. 2012 May 15;64(7):629-39. doi: 10.1016/j.addr.2011.12.005. Epub 2011 Dec 17.

Vitamin A and Alzheimer's disease

Ono K, Yamada M.

Geriatr Gerontol Int. 2012 Apr;12(2):180-8. doi: 10.1111/j.1447-0594.2011.00786.x. Epub 2011 Dec 23.

A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease

Anand P, Singh B, Singh N.

Bioorg Med Chem. 2012 Feb 1;20(3):1175-80. doi: 10.1016/j.bmc.2011.12.042. Epub 2011 Dec 30.

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

D'Onofrio G, Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Paroni G, Cascavilla L, Seripa D, Pilotto A.

Expert Opin Drug Discov. 2012 Jan;7(1):19-37. doi: 10.1517/17460441.2012.645534. Epub 2011 Dec 14.

Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors

Tayeb HO, Yang HD, Price BH, Tarazi FI.

Pharmacol Ther. 2012 Apr;134(1):8-25. doi: 10.1016/j.pharmthera.2011.12.002. Epub 2011 Dec 16.

Apolipoprotein E genotype-specific short-term cognitive benefits of treatment with the antihypertensive nilvadipine in Alzheimer's patients--an open-label trial

Kennelly S, Abdullah L, Kenny RA, Mathura V, Luis CA, Mouzon B, Crawford F, Mullan M, Lawlor B.

Int J Geriatr Psychiatry. 2012 Apr;27(4):415-22. doi: 10.1002/gps.2735. Epub 2011 May 10.

Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT

Kimura N, Kumamoto T, Masuda T, Hanaoka T, Okazaki T, Arakawa R.

J Neuroimaging. 2012 Jul;22(3):299-304. doi: 10.1111/j.1552-6569.2011.00612.x. Epub 2011 Jun 23.

Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study

Likitjaroen Y, Meindl T, Friese U, Wagner M, Buerger K, Hampel H, Teipel SJ.

Eur Arch Psychiatry Clin Neurosci. 2012 Jun;262(4):341-50. doi: 10.1007/s00406-011-0234-2. Epub 2011 Aug 5.

Alzheimer's therapeutics: translation of preclinical science to clinical drug development

Savonenko AV, Melnikova T, Hiatt A, Li T, Worley PF, Troncoso JC, Wong PC, Price DL.

Neuropsychopharmacology. 2012 Jan;37(1):261-77. doi: 10.1038/npp.2011.211. Epub 2011 Sep 21.

Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease

Mohamed S, Rosenheck R, Lyketsos CG, Kaczynski R, Sultzer DL, Schneider LS.

J Clin Psychiatry. 2012 Jan;73(1):121-8. doi: 10.4088/JCP.10m06574. Epub 2011 Sep 6.

Chronic treatment with rivastigmine in patients with Alzheimer's disease: a study on primary motor cortex excitability tested by 5 Hz-repetitive transcranial magnetic stimulation

Trebbastoni A, Gilio F, D'Antonio F, Cambieri C, Ceccanti M, de Lena C, Inghilleri M.

Clin Neurophysiol. 2012 May;123(5):902-9. doi: 10.1016/j.clinph.2011.09.010. Epub 2011 Oct 12.

Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study

Bettermann K, Arnold AM, Williamson J, Rapp S, Sink K, Toole JF, Carlson MC, Yasar S, Dekosky S, Burke GL.

J Stroke Cerebrovasc Dis. 2012 Aug;21(6):436-44. doi: 10.1016/j.jstrokecerebrovasdis.2010.11.002. Epub 2011 Jan 14.

Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing

Sona A, Zhang P, Ames D, Bush AI, Lautenschlager NT, Martins RN, Masters CL, Rowe CC, Szoeke C, Taddei K, Ellis KA; AIBL Research Group.

Int Psychogeriatr. 2012 Feb;24(2):197-204. doi: 10.1017/S1041610211001335. Epub 2011 Jul 13.

Copper and iron in Alzheimer's disease: a systematic review and its dietary implications

Loef M, Walach H.

Br J Nutr. 2012 Jan;107(1):7-19. doi: 10.1017/S000711451100376X. Epub 2011 Jul 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias